News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
806,272 Results
Type
Article (61229)
Company Profile (677)
Press Release (744338)
Multimedia
Podcasts (173)
Webinars (26)
Section
Business (220449)
Career Advice (2890)
Deals (38388)
Drug Delivery (162)
Drug Development (87736)
Employer Resources (189)
FDA (18157)
Job Trends (16493)
News (376775)
Policy (37812)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2977)
Academic (1)
Accelerated approval (49)
Adcomms (38)
Allergies (183)
Alliances (54427)
ALS (223)
Alzheimer's disease (1918)
Antibody-drug conjugate (ADC) (492)
Approvals (18470)
Artificial intelligence (759)
Autoimmune disease (311)
Automation (58)
Bankruptcy (393)
Best Places to Work (12443)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (426)
Bladder cancer (195)
Brain cancer (80)
Breast cancer (785)
Cancer (6112)
Cardiovascular disease (521)
Career advice (2460)
Career pathing (49)
CAR-T (358)
CDC (73)
Celiac Disease (3)
Cell therapy (983)
Cervical cancer (49)
Clinical research (75583)
Collaboration (2226)
Company closure (7)
Compensation (1434)
Complete response letters (100)
COVID-19 (3013)
CRISPR (118)
C-suite (1185)
Cystic fibrosis (160)
Data (8048)
Decentralized trials (3)
Denatured (51)
Depression (184)
Dermatology (89)
Diabetes (630)
Diagnostics (7409)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (358)
Drug pricing (242)
Drug shortages (38)
Duchenne muscular dystrophy (302)
Earnings (96712)
Editorial (76)
Employer branding (21)
Employer resources (163)
Events (128899)
Executive appointments (1145)
FDA (22033)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1831)
Gene editing (258)
Generative AI (71)
Gene therapy (806)
GLP-1 (1221)
Government (5375)
Grass and pollen (7)
Guidances (412)
Healthcare (20609)
HIV (85)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (334)
Immuno-oncology (102)
Indications (192)
Infectious disease (3384)
Inflammatory bowel disease (238)
Inflation Reduction Act (15)
Influenza (145)
Intellectual property (299)
Interviews (511)
IPO (17574)
IRA (59)
Job creations (4410)
Job search strategy (2024)
JPM (72)
Kidney cancer (21)
Labor market (106)
Layoffs (653)
Leadership (50)
Legal (9425)
Liver cancer (107)
Longevity (34)
Lung cancer (798)
Lymphoma (438)
Machine learning (62)
Management (64)
Manufacturing (1131)
MASH (201)
Medical device (14952)
Medtech (15080)
Mergers & acquisitions (22066)
Metabolic disorders (1668)
mRNA (240)
Multiple sclerosis (196)
NASH (21)
Neurodegenerative disease (458)
Neuropsychiatric disorders (123)
Neuroscience (3545)
Neurotech (1)
NextGen: Class of 2026 (7402)
Non-profit (5018)
Now hiring (78)
Obesity (804)
Opinion (358)
Ovarian cancer (226)
Pain (274)
Pancreatic cancer (307)
Parkinson's disease (383)
Partnered (34)
Patents (621)
Patient recruitment (701)
Peanut (67)
People (64035)
Pharmaceutical (123)
Pharmacy benefit managers (36)
Phase 1 (23509)
Phase 2 (33031)
Phase 3 (24766)
Pipeline (8934)
Policy (374)
Postmarket research (3056)
Preclinical (10140)
Press Release (71)
Prostate cancer (316)
Psychedelics (64)
Radiopharmaceuticals (347)
Rare diseases (1184)
Real estate (6763)
Recruiting (75)
Regulatory (28782)
Reports (64)
Research institute (2703)
Resumes & cover letters (471)
Rett syndrome (40)
RNA editing (25)
RSV (98)
Schizophrenia (190)
Series A (308)
Series B (227)
Service/supplier (26)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (184)
Sponsored (52)
Startups (4085)
State (2)
Stomach cancer (21)
Supply chain (136)
Tariffs (103)
The Weekly (119)
Vaccines (1246)
Venture capital (121)
Weight loss (558)
Women's health (128)
Worklife (23)
Date
Last 7 days (893)
Last 30 days (3525)
Last 365 days (32017)
2026 (13136)
2025 (32400)
2024 (37540)
2023 (42120)
2022 (53466)
2021 (58241)
2020 (57113)
2019 (50373)
2018 (38328)
2017 (35500)
2016 (35570)
2015 (41398)
2014 (35451)
2013 (30843)
2012 (32967)
2011 (33530)
2010 (31680)
Location
Africa (1014)
Alabama (99)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (47036)
Australia (7830)
California (13700)
Canada (3836)
China (1441)
Colorado (589)
Connecticut (607)
Delaware (419)
Europe (104615)
Florida (2039)
Georgia (446)
Hawaii (4)
Idaho (65)
Illinois (1130)
India (95)
Indiana (623)
Iowa (25)
Japan (553)
Kansas (138)
Kentucky (55)
Louisiana (45)
Maine (76)
Maryland (1678)
Massachusetts (9939)
Michigan (381)
Minnesota (750)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (29)
Nevada (149)
New Hampshire (90)
New Jersey (3620)
New Mexico (33)
New York (3596)
North Carolina (1818)
North Dakota (11)
Northern California (6790)
Ohio (413)
Oklahoma (26)
Oregon (51)
Pennsylvania (2732)
Puerto Rico (30)
Rhode Island (53)
South America (1392)
South Carolina (87)
South Dakota (2)
Southern California (5373)
Tennessee (215)
Texas (2206)
United States (48792)
Utah (407)
Vermont (1)
Virginia (352)
Washington D.C. (86)
Washington State (1116)
West Virginia (4)
Wisconsin (151)
Wyoming (2)
806,272 Results for "astellas pharma us inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform
Astellas Pharma and CytomX Therapeutics first partnered up in March 2020. For $80 million upfront, the Japanese pharma gained access to the biotech’s Probody platform to generate masked antibody therapies for cancer.
March 17, 2026
·
2 min read
·
Tristan Manalac
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.
December 10, 2025
·
7 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.
May 13, 2026
·
4 min read
·
Nick Paul Taylor
Patents
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
February 18, 2026
·
4 min read
·
Shawna Williams
Press Releases
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
April 20, 2026
·
3 min read
Press Releases
Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract
May 8, 2026
·
3 min read
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.
April 2, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Press Releases
MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS
April 9, 2026
·
5 min read
1 of 80,628
Next
